Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport.
Axonal degeneration contributes to permanent neurological disability in inherited and acquired diseases of myelin. Mitochondrial dysfunction has been proposed as a major contributor to this axonal degeneration. It remains to be determined, however, if myelination, demyelination, or remyelination alter the size and distribution of axonal mitochondrial stationary sites or the rates of axonal mitochondrial transport. Using live myelinated rat dorsal root ganglion (DRG) cultures, we investigated whether myelination and lysolecithin-induced demyelination affect axonal mitochondria. Myelination increased the size of axonal stationary mitochondrial sites by 2.3-fold. After demyelination, the size of axonal stationary mitochondrial sites was increased by an additional 2.2-fold and the transport velocity of motile mitochondria was increased by 47%. These measures returned to the levels of myelinated axons after remyelination. Demyelination induced activating transcription factor 3 (ATF3) in DRG neurons. Knockdown of neuronal ATF3 by short hairpin RNA abolished the demyelination-induced increase in axonal mitochondrial transport and increased nitrotyrosine immunoreactivity in axonal mitochondria, suggesting that neuronal ATF3 expression and increased mitochondrial transport protect demyelinated axons from oxidative damage. In response to insufficient ATP production, demyelinated axons increase the size of stationary mitochondrial sites and thereby balance ATP production with the increased energy needs of nerve conduction.
Kiryu-Seo
Sumiko
S
Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Ohno
Nobuhiko
N
Kidd
Grahame J
GJ
Komuro
Hitoshi
H
Trapp
Bruce D
BD
D051700:Activating Transcription Factor 3 / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001370:Axonal Transport / Q000502:physiology*; D001369:Axons / Q000473:pathology / Q000502:physiology*; D003711:Demyelinating Diseases / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology*; D005727:Ganglia, Spinal / Q000473:pathology / Q000503:physiopathology*; D055785:Gene Knockdown Techniques; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008244:Lysophosphatidylcholines; D008854:Microscopy, Electron; D008928:Mitochondria / Q000473:pathology / Q000502:physiology*; D009186:Myelin Sheath / Q000502:physiology; D018384:Oxidative Stress / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012583:Schwann Cells / Q000502:physiology; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism
D051700:Activating Transcription Factor 3; C497108:Atf3 protein, rat; D008244:Lysophosphatidylcholines; C002744:3-nitrotyrosine; D014443:Tyrosine
Exp Neurol. 2005 Apr;192(2):340-7
15755551
Brain. 2009 May;132(Pt 5):1161-74
19293237
J Cell Sci. 1993 Mar;104 ( Pt 3):917-27
8314882
J Neurosci Res. 2009 Feb;87(2):452-9
18803300
Annu Rev Neurosci. 2008;31:535-61
18558866
Cell. 2006 Jun 30;125(7):1241-52
16814712
J Neurosci. 2003 Jun 15;23(12):5187-96
12832543
Lancet Neurol. 2002 Aug;1(4):232-41
12849456
J Cell Sci. 2005 Dec 1;118(Pt 23):5411-9
16306220
J Neurosci Res. 2003 Jun 1;72(5):565-73
12749021
EMBO J. 2008 Jan 23;27(2):433-46
18200046
J Neurosci. 2007 Jul 25;27(30):7911-20
17652582
Am J Physiol. 1996 Nov;271(5 Pt 1):C1424-37
8944624
Mol Cell Neurosci. 2004 Nov;27(3):267-79
15519242
Mol Cell Neurosci. 2000 Feb;15(2):170-82
10673325
N Engl J Med. 1998 Jan 29;338(5):278-85
9445407
J Cell Biol. 1995 Dec;131(5):1315-26
8522592
Science. 1998 Jun 5;280(5369):1610-3
9616125
Nat Rev Neurosci. 2003 Sep;4(9):703-13
12951563
Acta Neuropathol. 1998 Aug;96(2):139-43
9705128
J Neurosci. 1999 Sep 1;19(17):7278-88
10460234
J Neuroimmunol. 2007 Aug;188(1-2):1-12
17493689
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20728-33
19098100
J Neurocytol. 1993 Nov;22(11):941-54
7507976
J Biol Chem. 2008 Mar 14;283(11):6988-96
18192274
J Neurosci. 2006 Jan 18;26(3):742-56
16421294
J Cell Sci. 2004 Jun 1;117(Pt 13):2791-804
15150321
J Neurol. 2004 Mar;251(3):261-8
15015004
Brain Pathol. 1999 Jan;9(1):69-92
9989453
Nature. 2006 Oct 19;443(7113):787-95
17051205
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8168-73
15148385
J Neurosci Res. 2006 Jun;83(8):1533-9
16555298
Annu Rev Neurosci. 2008;31:247-69
18558855
Mol Cell Neurosci. 2005 Jun;29(2):269-82
15911351
J Neurosci Res. 2004 Oct 15;78(2):157-66
15378614
Arch Biochem Biophys. 1998 Aug 1;356(1):1-11
9681984
Cell. 2009 Jan 9;136(1):163-74
19135897
Glia. 1999 Feb 1;25(3):216-28
9932868
Lancet Neurol. 2009 Mar;8(3):280-91
19233038
Exp Neurol. 2008 Feb;209(2):321-32
17720160
J Pathol. 2009 Oct;219(2):193-204
19591199
Ann Neurol. 1994 Nov;36(5):778-86
7526776
Ann Neurol. 2006 Mar;59(3):478-89
16392116
Curr Biol. 2004 Jul 27;14(14):1272-6
15268858
Neuroscience. 2006 Aug 25;141(2):727-736
16797853